LAMTOR5 and hepatocellular carcinoma: Studies have shown that HBXIP mediates the upregulation of methyltransferase-like 3 (METTL3) and promotes glycolysis by facilitating the methylation modification of HIF-1α, thereby enhancing the malignant biological behavior of HCC (84).